ID26730A - Induksi protein-protein dan peptida-peptida antibiotik oleh lait/scd14-protein - Google Patents
Induksi protein-protein dan peptida-peptida antibiotik oleh lait/scd14-proteinInfo
- Publication number
- ID26730A ID26730A IDW20002684A ID20002684A ID26730A ID 26730 A ID26730 A ID 26730A ID W20002684 A IDW20002684 A ID W20002684A ID 20002684 A ID20002684 A ID 20002684A ID 26730 A ID26730 A ID 26730A
- Authority
- ID
- Indonesia
- Prior art keywords
- scd14
- lait
- proteins
- induction
- protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8688498P | 1998-05-27 | 1998-05-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
ID26730A true ID26730A (id) | 2001-02-01 |
Family
ID=22201526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IDW20002684A ID26730A (id) | 1998-05-27 | 1999-05-27 | Induksi protein-protein dan peptida-peptida antibiotik oleh lait/scd14-protein |
Country Status (14)
Country | Link |
---|---|
US (1) | US7592310B2 (id) |
EP (1) | EP1080111B1 (id) |
JP (1) | JP2002516339A (id) |
CN (1) | CN1322214A (id) |
AU (1) | AU771448B2 (id) |
BR (1) | BR9910725A (id) |
CA (1) | CA2328134A1 (id) |
CZ (1) | CZ20004256A3 (id) |
HK (1) | HK1041892A1 (id) |
HU (1) | HUP0101987A3 (id) |
ID (1) | ID26730A (id) |
IL (1) | IL139339A0 (id) |
PL (1) | PL345208A1 (id) |
WO (1) | WO1999061468A2 (id) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2347069A1 (en) * | 1998-10-20 | 2000-04-27 | Societe Des Produits Nestle S.A. | Protein for treatment or prevention of a gastrointestinal tract disorder |
WO2001072993A1 (fr) * | 2000-03-31 | 2001-10-04 | Mochida Pharmaceutical Co., Ltd. | Inhibiteur de liaison entre le recepteur de type toll et cd14 |
AU2004241069B2 (en) | 2003-05-15 | 2010-09-09 | Genentech, Inc. | Methods and compositions for the prevention and treatment of sepsis |
ES2406266T3 (es) * | 2004-05-11 | 2013-06-06 | Mochida Pharmaceutical Co., Ltd. | Antígeno CD14 soluble novedoso |
WO2009095916A2 (en) * | 2008-01-29 | 2009-08-06 | The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center | Cd14 and peptides thereof for protection of cells against cell death |
ES2324192B1 (es) * | 2008-01-30 | 2010-06-17 | PUIG BEAUTY & FASHION GROUP, S.L. | Derivados peptidicos utiles en el tratamiento, cuidado o limpieza de la piel, mucosa, cuero cabelludo o uñas. |
DK2424890T3 (en) | 2009-04-27 | 2018-09-17 | Immuron Ltd | ANTI-LPS ENHANCED IMMUNOGLOBULIN PREPARATION FOR USE IN TREATMENT AND / OR PROPHYLAXY NONALCOHOLIC STEATOHEPATITIS |
ES2628032T3 (es) * | 2010-08-17 | 2017-08-01 | Immuron Limited | Preparación de inmunoglobulina enriquecida con anti-LPS para su uso en el tratamiento y/o la profilaxis de un trastorno patológico |
BR112013029645B1 (pt) * | 2011-05-19 | 2023-01-24 | Mochida Pharmaceutical Co., Ltd. | Método para detectar infecção respiratória, método para a seleção de pacientes com infecção respiratória, método para determinar o tempo para o fim da administração do antibiótico a um paciente com infecção respiratória e método para selecionar pacientes para o fim da administração de um antibiótico |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5543303A (en) | 1988-11-28 | 1996-08-06 | Goyert; Sanna M. | Recombinant myelomonocytic differentiation antigen CD14 |
ATE171042T1 (de) | 1989-08-01 | 1998-10-15 | Scripps Research Inst | Verfahren und zusammensetzungen zur verbesserung der symptome von sepsis |
WO1993019772A1 (en) * | 1992-04-06 | 1993-10-14 | North Shore University Hospital Research Corporation | A novel therapy for treating sepsis using a soluble form of recombinant cd14 myelomonocytic antigen |
AU695124B2 (en) | 1993-05-28 | 1998-08-06 | Scripps Research Institute, The | Methods and compositions for inhibiting CD14 mediated cell activation |
US5932536A (en) | 1994-06-14 | 1999-08-03 | The Rockefeller University | Compositions for neutralization of lipopolysaccharides |
US5714469A (en) | 1994-09-01 | 1998-02-03 | Smithkline Beecham Corporation | Method of treating sepsis |
US5766593A (en) | 1994-12-30 | 1998-06-16 | Amgen Inc. | Anti-inflammatory CD14 peptides |
AU691085B2 (en) * | 1994-12-30 | 1998-05-07 | Amgen, Inc. | Anti-inflammatory CD14 polypeptides |
WO1996032418A1 (en) | 1995-04-13 | 1996-10-17 | Laboratoires Om S.A. | Anti-cd14 antibodies for use in the induction of il-10 secretion |
PL185442B1 (pl) | 1996-10-03 | 2003-05-30 | Georgiades Biotech Ltd | Środek farmaceutyczny o działaniu immunologicznym i psychotropowym, jego postać terapeutyczna oraz zastosowanie |
US6093693A (en) * | 1996-11-18 | 2000-07-25 | The Wellesley Hospital Foundation | B cell activation |
US6248329B1 (en) | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
-
1999
- 1999-05-27 ID IDW20002684A patent/ID26730A/id unknown
- 1999-05-27 JP JP2000550872A patent/JP2002516339A/ja active Pending
- 1999-05-27 PL PL99345208A patent/PL345208A1/xx not_active Application Discontinuation
- 1999-05-27 CZ CZ20004256A patent/CZ20004256A3/cs unknown
- 1999-05-27 BR BR9910725-2A patent/BR9910725A/pt not_active Application Discontinuation
- 1999-05-27 AU AU40258/99A patent/AU771448B2/en not_active Ceased
- 1999-05-27 HU HU0101987A patent/HUP0101987A3/hu unknown
- 1999-05-27 CN CN99809165A patent/CN1322214A/zh active Pending
- 1999-05-27 CA CA002328134A patent/CA2328134A1/en not_active Abandoned
- 1999-05-27 EP EP99923333A patent/EP1080111B1/en not_active Expired - Lifetime
- 1999-05-27 WO PCT/CA1999/000482 patent/WO1999061468A2/en active IP Right Grant
- 1999-05-27 IL IL13933999A patent/IL139339A0/xx unknown
-
2002
- 2002-05-13 HK HK02103598.8A patent/HK1041892A1/zh unknown
-
2004
- 2004-07-15 US US10/891,105 patent/US7592310B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2328134A1 (en) | 1999-12-02 |
US7592310B2 (en) | 2009-09-22 |
WO1999061468A3 (en) | 2000-04-06 |
BR9910725A (pt) | 2001-01-30 |
IL139339A0 (en) | 2001-11-25 |
EP1080111A2 (en) | 2001-03-07 |
US20040259795A1 (en) | 2004-12-23 |
HUP0101987A2 (hu) | 2001-09-28 |
CZ20004256A3 (cs) | 2001-09-12 |
PL345208A1 (en) | 2001-12-03 |
CN1322214A (zh) | 2001-11-14 |
WO1999061468A2 (en) | 1999-12-02 |
JP2002516339A (ja) | 2002-06-04 |
AU771448B2 (en) | 2004-03-25 |
AU4025899A (en) | 1999-12-13 |
HUP0101987A3 (en) | 2010-01-28 |
HK1041892A1 (zh) | 2002-07-26 |
EP1080111B1 (en) | 2012-07-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO961796L (no) | Rekombinante fedme (ob) proteiner | |
DE69434520D1 (de) | Biotinylierung von proteinen | |
ATE458494T1 (de) | Von der telomerase abgeleitete antigene peptide | |
NO20016243D0 (no) | Anti-alfav-beta3-rekombinante humane antistoffer, nukleinsyrer som koder for de samme og fremgangsmåter foranvendelse | |
IS5375A (is) | KAY-nýstárlegt ónæmisprótín | |
DE69839603D1 (de) | Zierenden proteins | |
BR9709529A (pt) | Fragmentos de leptina (proteína ob) | |
DK0988861T3 (da) | Stabiliserede proteinpræparater | |
FR2755627B1 (fr) | Pipette multi-cylindre | |
DE69531958D1 (de) | (1-3)-beta-d-glukon-bindungsprotein, antikörper der dieses protein erkennt undverwendung des proteins und antikörper | |
BR9610239A (pt) | Proteínas de fusão-alérgeno-xcd32 | |
ID26730A (id) | Induksi protein-protein dan peptida-peptida antibiotik oleh lait/scd14-protein | |
ID21034A (id) | Protein kinase dan penggunaannya | |
ID19257A (id) | Protein-protein anti-obesitas | |
ATE295417T1 (de) | Angiostatin-bindendes protein | |
ID26903A (id) | Metode untuk menghasilkan protein terhidrolisis | |
NO20005547D0 (no) | Myelinbasiske proteinpeptider og anvendelser derav | |
NO992531D0 (no) | FremgangsmÕter ved fremstilling av rekombinant protein | |
DE69718579T2 (de) | Bestimmung von Proteinen | |
ID16711A (id) | Protein-protein obese (ob) rekombinan | |
ID30211A (id) | Protein baru dan penggunaannya | |
SE9801035D0 (sv) | New DNA sequences and proteins | |
SE9701041D0 (sv) | Novel proteins and their use | |
DE69841283D1 (de) | Polypeptide und dafür kodierende Nukleinsäure | |
SE9602287D0 (sv) | Novel protein and methods for its use |